US Broker Ratings

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: Analyzing the 16.72% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted medicines, continues to make significant strides in the biotechnology sector. With a market capitalization of $11.59 billion,..

Takeda Pharmaceutical (TAK) Stock Analysis: A 23% Potential Upside Amidst Strategic Collaborations

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the healthcare sector, is drawing significant attention from investors with a promising potential upside of 23.27%...

Moderna, Inc. (MRNA) Stock Analysis: Evaluating a 58% Potential Upside Amidst Biotech Challenges

In the ever-evolving world of biotechnology, Moderna, Inc. (NASDAQ: MRNA) remains a compelling name for investors seeking both innovation and future growth potential. Despite recent financial..

Legend Biotech Corporation (LEGN): Investor Outlook with 148% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is capturing significant attention in the biotechnology sector with its groundbreaking innovations in cell therapy, particularly in oncology. Positioned at the..

Stryker Corporation (SYK) Investor Outlook: Exploring a Potential 18.43% Upside in the Medical Device Giant

Stryker Corporation (NYSE: SYK), a formidable player in the healthcare sector, is catching the attention of savvy investors with its robust market presence and promising growth..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 41% Potential Upside Amid Healthcare Sector Stability

Investors eyeing opportunities within the healthcare sector might want to pay close attention to Zoetis Inc. (NYSE: ZTS), a prominent player in the animal health industry...

GE HealthCare Technologies Inc. (GEHC) Investor Outlook: Strong Buy Ratings and a 20.90% Upside Potential

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a prominent player in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Analysts See 28.67% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector, particularly among investors eyeing the healthcare space. With a market capitalization of $7.04 billion,..

Boston Scientific Corporation (BSX) Stock Analysis: 23% Upside Potential and Strong Analyst Support

Boston Scientific Corporation (NYSE: BSX), a leading player in the healthcare sector, stands out with a compelling investment case bolstered by a robust market cap of..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 65% Upside Potential in Biotech Innovation

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology sector, with a market capitalization of $10.51 billion. Specializing in therapies for rare..

Masimo Corporation (MASI) Stock Analysis: Exploring a 23% Potential Upside for Investors

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector, specifically in the medical devices industry, offers a compelling investment opportunity with a notable 23.18%..

Waystar Holding Corp. (WAY) Stock Analysis: A 40.62% Potential Upside in the Health Information Sector

Waystar Holding Corp. (WAY), a key player in the healthcare information services industry, is capturing investor attention with its potential upside of 40.62%. This Utah-based company..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential Amid Market Volatility

Illumina, Inc. (NASDAQ: ILMN), a key player in the healthcare sector’s diagnostics and research industry, is at the forefront of genetic and genomic analysis worldwide. With..

Doximity, Inc. (DOCS) Investor Outlook: Analyzing a 39.16% Potential Upside in the Healthcare Sector

Investors with a keen eye on healthcare technology stocks should take note of Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services industry...

HealthEquity, Inc. (HQY): Investor Outlook Highlights 18% Upside Potential

For investors seeking to capitalize on growth in the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents an intriguing opportunity. Specializing in technology-enabled services for health savings..

Henry Schein, Inc. (HSIC) Stock Analysis: Insights into a Healthcare Giant with a 7.80% Potential Upside

Investors eyeing the healthcare sector may want to consider Henry Schein, Inc. (NASDAQ: HSIC), a leading player in medical distribution with a robust market capitalization of..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating Growth with a Potential 8.86% Upside

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, is a company that has built its reputation on delivering innovative cardiovascular solutions...

Elanco Animal Health (ELAN) Stock Analysis: Evaluating Growth Potential Amid a 12.94% Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and..

Grifols, S.A. (GRFS) Investor Outlook: Analyzing a 43.8% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) is a notable player in the healthcare sector, specifically within the drug manufacturing industry, with a strong foothold in the plasma therapeutics..

Bruker Corporation (BRKR) Stock Analysis: A Look at Its 14.89% Potential Upside

Bruker Corporation (NASDAQ: BRKR), a formidable player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. With a market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds